Michael Arenberg - Nov 8, 2022 Form 4 Insider Report for Imago BioSciences, Inc. (IMGO)

Role
Chief Operating and Business Officer
Signature
/s/ Hugh Rienhoff, as Attorney-in-fact for Michael Arenberg
Stock symbol
IMGO
Transactions as of
Nov 8, 2022
Transactions value $
$0
Form type
4
Date filed
11/14/2022, 05:56 PM
Previous filing
Mar 25, 2022
Next filing
Dec 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGO Stock Option (Right to Buy) Award $0 +103K $0.00 103K Nov 8, 2022 Common Stock 103K $15.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 8, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Remarks:

Chief Operating and Business Officer